News from Immundiagnostik

Company

In Vitro Diagnostic Regulation Update

Immundiagnostik has been implementing the European Regulation on In Vitro Diagnostics (IVDR …
Company

Colon Cancer Awareness

Colorectal carcinoma, i.e. cancer of the colon or rectum, is the third most frequent cause of …
Company

Fecal biomarkers – diagnostic possibilities in the context of inflammatory bowel disease

Inflammatory bowel disease (IBD), mainly divided into Crohn's disease (CD) and ulcerative colitis …
Company

IDK Portfolio for Colorectal Cancer Screening

Regular participation in colorectal cancer (CRC) screening programmes can reduce the number of …
Company

Faecal immunochemical tests for colorectal cancer screening

Bowel cancer is one of the most common types of cancer worldwide. In Germany, about 60,000 people …
Company

Colon Cancer Awareness

March is Colon Cancer Awareness month. IDK wants to help spreading awareness on how the disease …
Company

REACH-compliant products

The EU Regulation concerning the Registration, Evaluation, Authorization and Restriction of …
Company

The test center´s new website

Since 18.11.21 you can also make your appointments at the CORONA Test Center of Immundiagnostik AG …
Company

Sustainability at Immundiagnostik – IDK® goes green

We also care about our environment. Therefore, since January 2021, we have been supplying our test …
Company

New production- and storage facility

Location Bensheim IDK 2.0 Only 800 meters away from our main building in Stubenwald-Allee, we have …
Results: 1 - 10 from 10